Daesung Microbiological Labs. Co. Ltd Logo

Daesung Microbiological Labs. Co. Ltd

Researches and manufactures veterinary vaccines and medicines for livestock, fish, and canines.

036480 | KO

Overview

Corporate Details

ISIN(s):
KR7036480002
LEI:
Country:
South Korea
Address:
경기도 의왕시 덕영대로 103, 의왕시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Daesung Microbiological Labs. Co., Ltd. is a veterinary pharmaceutical company engaged in the research, manufacture, and sale of animal medicines. Established in 1968, the company has over half a century of experience contributing to the health of the livestock industry. Its product portfolio includes a wide range of vaccines, antibiotics, and other therapeutic drugs for various animals, including swine, poultry, cattle, canines, and fish. As a leading vaccine manufacturer with KGMP (Korean Good Manufacturing Practice) certification, the company focuses on producing high-quality products aimed at disease prevention and promoting animal welfare.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 749.2 KB
2025-06-26 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
Korean 14.1 KB
2025-06-23 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
Korean 14.1 KB
2025-05-26 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
Korean 14.5 KB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 756.0 KB
2025-03-26 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 25.7 KB
2025-03-18 00:00
Audit Report / Information
감사보고서제출
Korean 18.8 KB
2025-03-18 00:00
Annual Report
사업보고서 (2024.12)
Korean 928.0 KB
2025-03-10 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 120.2 KB
2025-02-25 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 9.2 KB
2025-02-11 00:00
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 10.8 KB
2025-02-11 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정
Korean 8.8 KB
2024-12-13 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2024-11-13 00:00
Quarterly Report
분기보고서 (2024.09)
Korean 653.8 KB
2024-08-26 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 20.9 KB

Automate Your Workflow. Get a real-time feed of all Daesung Microbiological Labs. Co. Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Daesung Microbiological Labs. Co. Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Daesung Microbiological Labs. Co. Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Apellis Pharmaceuticals, Inc. Logo
Developing novel C3 therapies for diseases in ophthalmology, nephrology, and hematology.
United States of America
APLS
Apimeds Pharmaceuticals US, Inc. Logo
Biopharma developing non-narcotic bee venom therapies for osteoarthritis pain and inflammation.
United States of America
APUS
Apogee Therapeutics, Inc. Logo
Developing novel antibody biologics for immunological and inflammatory (I&I) diseases.
United States of America
APGE
Apollomics Inc. Logo
A clinical-stage biopharma developing targeted oncology therapies for hard-to-treat cancers.
United States of America
APLM
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany
APPH
Develops DNA tech for genetic medicine, molecular diagnostics, and supply chain security.
United States of America
APDN
Applied Therapeutics, Inc. Logo
Develops treatments for rare metabolic and central nervous system (CNS) disorders.
United States of America
APLT
Aprea Therapeutics, Inc. Logo
Developing precision cancer therapies targeting DNA Damage Response for solid tumors.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases and oncology using its SAFA™ platform.
South Korea
397030
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologic drugs and biosimilars for the professional market.
South Korea
003060

Talk to a Data Expert

Have a question? We'll get back to you promptly.